Human embryonic pancreas-derived cell line. See RCB0794,0795,0797.
Comment from the depositor
Terms and conditions
A prior written permission of the approver(Depositor) is necessary for any kind of use including academic use and for-profit use.
Contact Us firstname.lastname@example.org RIKEN, BioResource Research Center Cell Engineering Division
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, Category I and II, depending on the sort of user institutions and the purposes of use.Please use an appropriate MTA(to see).In case of Restriction "a" or "f", please contact RIKEN BRC(email@example.com) regarding any kind of for-profit use.
Shoji Y, Miyamoto M, Ishikawa K, Yoshioka T, Mishra R, Ichinokawa K, Matsumura Y, Itoh T, Shinohara T, Hirano S, Kondo S.
The CD40-CD154 interaction would correlate with proliferation and immune escape in pancreatic ductal adenocarcinoma.
J Surg Oncol
PubMed ID: 21337550
Mishra R, Miyamoto M, Yoshioka T, Ishikawa K, Matsumura Y, Shoji Y, Ichinokawa K, Itoh T, Shichinohe T, Hirano S, Kondo S.
Adenovirus-mediated eukaryotic initiation factor 4E binding protein-1 in combination with rapamycin inhibits tumor growth of pancreatic ductal adenocarcinoma in vivo.
Int J Oncol
PubMed ID: 19360336